Best Income Stocks To Own Right Now

Stocks dropped today as minutes from last month’s Fed meeting spooked investors as JPMorgan Chase (JPM), Boeing (BA), Home Depot (HD), Cliffs Natural Resources (CLF) and Comcast (CMCSA) fell.

The S&P 500 dropped 0.7% to 1,828.75 today–ending a three-day win streak–while the Dow Jones Industrial Average fell 0.6% to 16,040.56, its second consecutive loss. The 10-year yield rose 0.02 percentage point to 2.73%.

JPMorgan Chase fell 2.1% to $57.26, while Boeing dropped 1.7% to $128.39 despite receiving a large order. Home Depot declined 1.4% to $76.45 after housing starts fell 16% in January. Cliffs Natural Resources fell 3.4% to $21.96 and Comcast dropped 3.7% after the FCC proposed new net neutrality rules.

Interactive Brokers’ Andrew Wilkinson explains what spooked the market:

Best Income Stocks To Own Right Now: LMI Aerospace Inc.(LMIA)

LMI Aerospace, Inc. provides design engineering services, structural assemblies, kits, and components to the aerospace, defense, and technology markets primarily in the United States. The company operates in two segments, Aerostructures and Engineering Services. The Aerostructures segment fabricates, machines, finishes, integrates, assembles, and kits formed close tolerance aluminum, specialty alloy, and composite components, as well as higher level assemblies. Its aerospace products include wing slats and flapskins; winglet leading edges and related wing modification kits; fuselage and wing skins; helicopter cabin, aft section, and pylon components and assemblies; door surrounds, components, assemblies, and floorbeams; thrust reversers and engine nacelles/cowlings; cockpit window frames and landing light lens assemblies; interior components; structural sheet metal and extruded components; tailcone assemblies; and housings and assemblies. This segment also offers value-add ed services related to the design, production, assembly, and distribution of aerospace components. The Engineering Services segment provides design, engineering, and program management services, such as structural design and analysis, systems design and integration, tool design and fabrication, certification planning support, risk mitigation and producibility trade studies, and the development of program schedules and resource planning. Its services include wing/wingbox, fixed and moveable leading edges/trailing edges, fuselage, empennage, and tailcone design; winglet/wing mod design; nacelle, engine cowl, and thrust reverser design; weight improvement engineering; helicopter fuselage, cockpit, cabin frames, skins, longerons, and beams; aircraft modification engineering; aviation training system; aviation maintenance engineering; manufacturing engineering; and aviation system software engineering. The company was founded in 1948 and is based in St. Charles, Missouri.

Advisors’ Opinion:

  • [By Sally Jones] % over 12 months, Lockheed Martin Corporation (LMT) has a market cap of $45.06 billion. The current share price is $140.67, and trades with a P/E of 15.00. The dividend yield is 3.30%.

    Lockheed Martin Corporation was formed in 1995 by combining the businesses of Lockheed Corporation and Martin Marietta Corporation. Lockheed Martin operates in four principal business segments: Aeronautics, Electronic Systems, Information Systems & Global Services and Space Systems.

    Guru Action: As of Sept. 30, 2012, Jim Simons bought a new holding of 145,800 shares at an average price of $121.40 for a gain of 15.9%.

    Guru Ray Dalio sold out his LMT after 16 quarters of high gains. In the third quarter of 2013, he sold 10,176 shares at an average price of $121.40 for a gain of 15.9%.

    Numerous gurus traded LMT in third quarter.

    There is recent insider selling.

    Historical share pricing, revenue and net income tracking:

    [ Enlarge Image ]

    B/E Aerosp ace Inc. (BEAV)

    Up 93% over 12 months, B/E Aerospace Inc. has a market cap of $9.05 billion.

    The current share price is $86.28, and trades with a P/E of 25.60. The company does not pay a dividend.

    B/E Aerospace Inc. is a global manufacturer of aircraft cabin interior products and a distributor of aerospace fasteners and consumables.

    Guru Action: As of Sept. 30, 2012, Guru Ken Fisher is one of four gurus making a new buy. Fisher bought a new holding of 21,800 shares at an average price of $70.20 for a gain of 23%.

    Guru Larry Robbins was one of two gurus selling out in the third quarter. Robbins sold 341,692 shares at an average price of $70.20 for a gain of 22.9%.

    Here’s a lot more guru action and recent insider selling.

    [ Enlarge Image ]

    GuruFocus “Real Time Picks” reports the stock purchases and sales that Gurus have made within the prior 2 weeks. The report time lag can be as short as 2 days after the date of the trans action. This feature

Best Income Stocks To Own Right Now: Trans World Entertainment Corp.(TWMC)

Trans World Entertainment Corporation, through its subsidiaries, operates as a specialty retailer of entertainment software products, including music, video, video games, and other related products through its retail stores and e-commerce sites in the United States. The company?s other related products include electronics, accessories, and trend items. As of January 29, 2011, it operated 376 mall-based stores under the For Your Entertainment (f.y.e.), Suncoast Motion Pictures, and Saturday Matinee brand names in regional shopping malls; 84 freestanding stores under the f.y.e. brand name; and 3 retail Websites, including,, and The company operates retail stores in the United States, the District of Columbia, the Commonwealth of Puerto Rico, and the U.S. Virgin Islands. Trans World Entertainment Corporation was founded in 1972 and is headquartered in Albany, New York.

Advisors’ Opinion:

  • [By Tim Melvin]

    The safe and cheap undervalued stocks will go right up, but your chances of being destroyed when the party is over are diminished. Stocks like Richardson Electronics (RELL) and Transworld Entertainment (TWMC) have the ability to go up as the market bubbles higher but their asset value will act as sort of a floor in a decline.

Best Income Stocks To Own Right Now: Amkor Technology Inc.(AMKR)

Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States and internationally. It offers package formats and services using wirebonding and flip chip interconnect technologies that connect the die to the package carrier. The company?s package carriers include leadframe packages that utilize metal and place the electrical interconnect leads to the system board around the perimeter of the package; substrate packages, which utilize a laminate as the package carrier; and wafer-level packages. It provides chip scale packages comprising stacked chip scale packages for chipsets and memory applications; package-on-package solutions for the integration of logic and memory in a single footprint; and system-in-package modules that integrate two or more chips and passive device elements into a single package. The company also offers ball grid array packages comprising flip chip ball grid array packages that are used with silicon nodes f or small devices and other applications; and plastic ball grid array packages, which use wirebond technology. In addition, it provides other packaging services, such as wafer bumping services. Further, the company offers semiconductor testing services, including wafer testing or probe, final testing, strip testing, and end-of-line test services; and specialized logistical services, such as security certification and anti-counterfeit measures. It primarily serves the communications, consumer, computing, networking, automotive, and industrial markets. Amkor Technology, Inc. was founded in 1968 and is headquartered in Chandler, Arizona.

Advisors’ Opinion:

  • [By Louis Navellier]

    Amkor Technologies (AMKR) outsources semiconductor packaging and test services both in the U.S. and around the world. Amkor has 16 facilities with over 5.5 million square feet of space in seven countries right now. Analysts expected the company to have a very weak first quarter, but Amkor exceeded expectations by a wide margin.

  • [By Monica Gerson]

    Amkor Technology (NASDAQ: AMKR) shares gained 1.63% to touch a new 52-week high of $7.46. Amkor Technology’s PEG ratio is 0.94.

    Abraxas Petroleum (NASDAQ: AXAS) shares gained 2.94% to reach a new 52-week high of $4.55. Abraxas Petroleum shares have jumped 93.01% over the past 52 weeks, while the S&P 500 index has gained 17.50% in the same period.

  • [By Alex Planes]

    What: Shares of Amkor Technology (NASDAQ: AMKR  ) are up by over 10% today after beating expectations on both top and bottom lines in its first-quarter earnings report.

Best Income Stocks To Own Right Now: Salix Pharmaceuticals Ltd (SLXP)

Salix Pharmaceuticals, Ltd., incorporated on December 31, 2001, is a specialty pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs and medical devices used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract. As of December 31, 2012, the Company’s products included XIFAXAN, MOVIPREP, APRISO, RELISTOR, OSMOPREP, SOLESTA, DEFLUX, FULYZAQ, GIAZO, METOZOLV ODT, AZASAN, ANUSOL-HC, PROCTOCORT, PEPCID, DIURIL and COLAZAL. As of December 31, 2012, its primary product candidates under development included Rifaximin, Methylnaltrexone bromide oral, Budesonide foam and Rifaximin EIR. In January 2014, Salix Pharmaceuticals, Ltd. acquired Santarus, Inc.

Xifaxan (rifaximin) tablets

Xifaxan is a gastrointestinal-specific oral antibiotic. The Food and Drug Administration ( FDA) approved Xifaxan 200 milligram for the treatment of patients 12 years of age and older with travelers’ diarrhea caused by noninvasive strains of E coli. Xifaxan 550 milligram was approved by the FDA for reduction in risk of overt hepatic encephalopathy (HE), recurrence in patients 18 years of age or older.

It launched Xifaxan 200milligram in the United States and Xifaxan 550 milligram using its own direct sales force. The Company is exploring potential additional indications, formulations, clinical trials and co-promotion arrangements to capitalize on the potential for Xifaxan, including its development program in irritable bowel syndrome.

In October 2012, the USPTO declared an interference action to determine the priority of invention between Cipla’s application related to amorphous rifaximin and Solmag SpA’s application directed to amorphous rifaximin. In February 2012, the FDA posted draft bioequivalence guidance for rifaximin 550 milligram tablets. The draft guidance for rifaximin 550 milligram tablets recommends that in ad dition to conducting the program outlined in the FDA posted ! draft guidance document for rifaximin 200 milligram tablets discussed above, a single-dose, three-way crossover in-vivo study of fasting bioequivalence with pharmacokinetic endpoints in both fasting and fed states be performed in the 550 milligram tablets. Additionally, the guidance stipulated that the formulation of the 550 milligram strength should be proportionally similar to that of the 200 milligram strength in order to file an ANDA for approval of a generic rifaximin 550 milligram tablet for the treatment of hepatic encephalopathy.

MoviPrep (PEG 3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid) oral solution

MoviPrep is a patent-protected, liquid polyethylene glycol-salt, or PEG, bowel cleansing product that the FDA approved. MoviPrep is indicated for bowel cleansing prior to colonoscopy, intestinal surgery and barium enema X-ray examinations.

Apriso (mesalamine) extended-release capsu les 0.375 gram

Apriso is a locally-acting aminosalicylate and is the only delayed and extended release mesalamine product approved by the FDA for once-a-day dosing for the maintenance of remission of ulcerative colitis. Apriso is designed to provide for the distribution of the active ingredient beginning in the small bowel and continuing throughout the colon. The product’s prolonged release mechanism might allow them to expand the range of treatment options for ulcerative colitis.

Relistor (methylnaltrexone bromide)

Relistor Subcutaneous Injection is indicated for the treatment of opioid-induced constipation (OIC) in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient. Relistor is approved for use in over 55 countries worldwide.

OsmoPrep and Visicol (sodium phosphate monobasic monohydrate, USP, sodium phosphate dibasic anhydrous, USP) tablets

Visicol and OsmoPrep tablets are indicated for clean! sing of t! he colon as a preparation for colonoscopy in adults 18 years of age or older. Visicol and OsmoPrep are the only, tablet bowel cleansing products approved by the FDA and marketed in the United States. OsmoPrep is a patented, second-generation tablet bowel cleansing product that the FDA approved. OsmoPrep offers potential benefits compared to Visico,l such as its lack of microcrystalline cellulose, smaller tablet size and possible lower dose administration.


Solesta is a biocompatible tissue bulking agent, consisting of dextranomer microspheres and stabilized sodium hyaluronate. Solesta is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy, such as diet, fiber therapy and/or anti-motility medications. It is the only injectable gel for this indication to be administered in an outpatient setting without the need for surgery or anesthesia.


Deflux i s a medical device indicated for children affected by Grades II-IV vesicoureteral reflux, a malformation of the urinary bladder that can result in severe infections of the kidneys and irreversible kidney damage. Deflux was granted premarket approval application (PMA) approval, and has been on the market in the United States.

Fulyzaq (crofelemer) delayed-release tablets

On December 31, 2012, the FDA granted marketing approval for this product, under the trade name Fulyzaq. Fulyzaq is indicated for the symptomatic relief of non-infectious diarrhea in adult patients with HIV/AIDS on anti-retroviral therapy. Fulyzaq should also be eligible for five years of marketing exclusivity from the date of FDA approval, and the product might be entitled to patent term restoration.

Giazo (balsalazide disodium) tablets

February 3, 2012, the FDA granted marketing approval for this product under the trade name Giazo. Giazo is indicated for the treatment of mildly to moderately active ulcerative col! itis in m! ale patients 18 years of age and older. It shipped Giazo to wholesalers in 2012.

Metozolv ODT (metoclopramide hydrochloride) 5 milligrams and 10 milligrams orally disintegrating tablets

METOZOLV ODT is indicated for the relief of symptomatic gastroesophageal reflux or short-term (4-12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy and diabetic gastroparesis or the relief of symptoms in adults associated with acute and recurrent diabetic gastroparesis.

Azasan (azathioprine) tablets

Azasan is an FDA-approved drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. It launched the 75 and 100 milligrams dosage strengths of Azasan in the United States.

Anusol-HC and Proctocort (hydrocortisone) creams and suppositories

The Company acquired t he right to sell Anusol-HC 2.5% (hydrocortisone USP) cream, Anusol-HC 25 milligrams (hydrocortisone acetate) rectal suppositories, Proctocort 1% (hydrocortisone USP) cream and Proctocort 30 mg (hydrocortisone acetate) rectal suppositories from King Pharmaceuticals, Inc. The two cream products are topical corticosteroids indicated for relief of the inflammatory and pruritic, or itching, manifestations of corticosteroid-responsive dermatoses. The two suppository products are indicated for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and other inflammatory conditions.

Pepcid (famotidine) for Oral Suspension and Diuril (Chlorothiazide)

Pepcid Oral Suspension is a widely known prescription pharmaceutical product indicated for several gastrointestinal indications, including the treatment of duodenal ulcer, benign gastric ulcer and gastro-esophageal reflux disease. Pepcid Oral Suspension and Diuril Oral Suspension, both liquid form! ulations ! of their solid dosage form counterparts, compete in a combined annual United States market concentrated in pediatric and hospitalized patient populations.

Colazal (balsalazide disodium) capsules

The Company launched Colazal to physicians in the United States. FDA approved Colazal for use in pediatric patients between 5 to 17 years of age with ulcerative colitis. The pediatric use of Colazal has been granted orphan drug designation. The Office of Generic Drugs, or OGD, approved three generic balsalazide capsule products.

The Company competes with GlaxoSmithKline plc, Giuliani S.p.A., Axcan Pharma, Inc., Abbott Laboratories, Warner Chilcott plc, Shire Pharmaceuticals Group plc, Pharmacia & Upjohn, Inc., Alaven Pharmaceutical LLC, Ferring Pharmaceuticals, Inc, Takeda Pharmaceutical Company Limited, Cumberland Pharmaceuticals, Inc, Prometheus Laboratories, Inc., Ranbaxy Pharmaceuticals, Ferndale Laboratories, GATE Pharmaceuticals , Nycomed , Medtronic, Inc., and Cubist Pharmaceuticals, Inc.

Advisors’ Opinion:

  • [By David Williamson]

    In this segment, health-care analyst David Williamson takes a look at the upcoming acquisition by Salix Pharmaceuticals (NASDAQ: SLXP  ) of Santarus (NASDAQ: SNTS  ) for about $2.6 billion. Salix is currently a maker of drugs for gastrointestinal diseases, and the immediately accretive deal will give Salix access to treatments for both diabetes and heartburn. Shares of both companies were up significantly on the news. David tells investors why shareholders should be pleased with this deal on both ends and what he thinks of the stock going forward.

  • [By Jake L’Ecuyer]

    Equities Trading UP
    Santarus (NASDAQ: SNTS) shot up 37.95 percent to $32.03 after Salix Pharmaceuticals (NASDAQ: SLXP) announced its plans to buy Santarus for around $2.12 billion. Santarus and Pharming also announced new data from open-label repeat treatment study with RUCONEST.

  • [By Paul Ausick]

    Stocks on the Move: Twitter Inc. (NYSE: TWTR) is down 7.3% at $41.64 on its second day of trading and word is that some hedge funds and traders are looking to borrow shares. Santarus Inc. (NASDAQ: SNTS) is up 37.6% at $31.95 after agreeing late Thursday night to an acquisition by Salix Pharmaceuticals Inc. (NASDAQ: SLXP) for $2.6 billion in cash.

  • [By Lisa Levin]

    Santarus (NASDAQ: SNTS) shares surged 37.64% to touch a new 52-week high of $31.96 after Salix Pharmaceuticals (NASDAQ: SLXP) announced its plans to buy Santarus for around $2.12 billion. Santarus and Pharming also announced new data from open-label repeat treatment study with RUCONEST.

Best Income Stocks To Own Right Now: Players Network (PNTV)

Players Network (PNTV), incorporated on March 16, 1993, is a global media and entertainment company engaged in the development of Digital Networks. The Company distributes broadband video and other social media content over a range of Internet enabled devices and cable television channels. The Company’s platform is designed to deliver video content and develop digital social communities, including Vegas On Demand TV. The Company operates a video on demand (VOD) television channel, also named Vegas On Demand, which consists of original programming that is distributed over its own VOD channels to approximately 24,000,000 homes over the Internet with distribution partners, which include, Comcast, Hulu, Blinkx, Google, and YouTube Video, for DVD home video, and various mobile platforms. Vegas On Demand TV offers its audience the ability to connect to Vegas Insiders through programming, which captures sex appeal, entertainment, and the non-stop adrenaline rush of the Las Vega s gaming lifestyle. Players Network’s content goes beyond poker, casino action, sports betting, and racing, to lifestyle programs about entertainment and fine living.

PNTV’s Media Network operates across all distribution platforms from television screens to mobile devices, gaming consoles, computers and tablets. The Company’s platform has two main membership categories: the Consumer/User who visits its digital communities and partakes in viewing ad-supported and pay-per-view premium videos, purchases products and connects with Insiders, who are its Premium Members. Players Network’s Programming Brands include Vegas On Demand focuses on Gaming lifestyle and produces programming about Horse Racing, Sports Betting, Casino Games and Poker; Vegas On Demand, which is about Las Vegas lifestyle and covers celebrity, night clubs, poolside experiences and entertainment, and Sexy Sin City TV covers the adult and sexy side of Las Vegas after dark. The Company’s p roductions include gaming instruction, gaming news, instruct! ion on sports and racing wagering, gaming entertainment, tournaments, events and travel. The Company has a library of 1,550 gambling and gaming lifestyle videos, including several series of both long and short form content. Some of these series include Players Network originals; Hidden Vegas, Tattoo Tails, which include 30 originally produced hours of programming from the World Series of Poker, which Players Network had the rights to produce and air live. Players Network produced over 50 videos at the Hooters Hotel and Casino, 28 new gaming instructional videos aimed at slots and video poker players, a series of 23 videos on magic entitled Hocus Pocus, The Best of Vegas series and Neon Buzz, an entertainment report which covered red carpet events.

The Company competes with ESPN, the Travel Channel, E! and the Food Network.

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap entertainment or gaming stocks Soul and Vibe Interactive Inc (OTCBB: SOUL), Elray Resources Inc (OTCMKTS: ELRA) and Players Network (OTCMKTS: PNTV) focus on entertaining consumers. However, its important to remember that consumers can be very fickle when it comes to entertainment or games. So should you be entertaining any of these small caps? Here is a closer look and a reality check:

Best Income Stocks To Own Right Now: HealthSouth Corporation (HLS)

HealthSouth Corporation offers inpatient rehabilitative healthcare services in the United States and Puerto Rico. The company primarily operates inpatient rehabilitation hospitals and long-term acute care hospitals, which provide treatment on both an inpatient and outpatient basis. Its inpatient rehabilitation hospitals offer services to patients who require institutional rehabilitation care, and patient care is provided by nursing and therapy staff as directed by a physician order. As of December 31, 2010, the company operated 97 inpatient rehabilitation hospitals, including 68 owned hospitals and 29 jointly owned hospitals; 6 freestanding long-term acute care hospitals; 32 outpatient rehabilitation satellite clinics; 25 licensed hospital-based home health agencies; and managed 4 inpatient rehabilitation units through management contracts. The company was founded in 1983 and is headquartered in Birmingham, Alabama.

Advisors’ Opinion:

  • [By Maria Armental var popups = dojo.query(“.socialByline .popC”); popups.forEach]

    HealthSouth Corp.(HLS) said it expects to exceed its earnings projections after it increased its ownership interest in Fairlawn Rehabilitation Hospital, in Worcester, Mass.

  • [By Brad Thomas]

    As the only healthcare REIT with a "hospital-focused" platform, MPW is a relatively new REIT that was formed (in 2004) to lease from many of the nation’s leading hospital operators, including Prime Healthcare Services, Kindred Healthcare (KND), HealthSouth (HLS), Health Management Associates (HMA), Community Health Systems (CYH), Vibra Healthcare, Ernest Health Inc., and IASIS Healthcare.

Best Income Stocks To Own Right Now: Dex Media Inc (DXM)

Dex Media, Inc., incorporated on August 17, 2012, is a provider of social, local and mobile marketing solutions for local businesses. The Company provides marketing solutions that include Websites, print, mobile, search engine and social media solutions. The Company’s brands include Dex One and SuperMedia. Through both brands, it delivers a range of social, mobile, and print solutions.

The Company’s consumer services include the Dex and online and mobile search portals and applications and local print directories. On April 30, 2013, Dex One Corporation and SuperMedia Inc. announced the completion of their merger, creating Dex Media, Inc.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Since the last conference, for every winning pick like Akamai Technolgies (AKAM)–which gained 19% after being picked by Blue Harbour Group’s Clifton Robbins–or Digital Realty Trust (DLR)–which rose fell 27.5% after being picked as a short by Jonathon Jacobson of Highfields Capital Management–there’s been a stinker like Chipotle Mexican Grill (CMG)–which gained 29% after Double Line’s Jeffrey Gundlach recommended shorting it–or Dex Media (DXM)–which advanced 53.7% after Hayman Capital’s Kyle Bass recommended selling. In fact, the average pick lost 3.8%, even as the S&P 500 gained 15.2%.

  • [By Roberto Pedone]

    Dex Media (DXM) is a provider of marketing solutions that include Web sites, print, mobile, search engine and social media solutions for local businesses, through its Dex One and SuperMedia Marketing Consultants. This stock closed up 5.6% at $10.25 in Thursday’s trading session.

    Thursday’s Volume: 471,000

    Three-Month Average Volume: 280,277

    Volume % Change: 105%

    From a technical perspective, DXM spiked sharply higher here right above some near-term support at $9 with above-average volume. This stock has been downtrending badly for the last four months, with shares plunging lower from its low of $23.86 to its recent low of $8.85. During that move, shares of DXM have been consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of DXM have started to see its downside volatility stop as the stock has rebound off oversold levels. This stock got so oversold that its relative strength index reading recently dipped below 20. Shares of DXM are now starting to move within range of triggering a big breakout trade. That trade will hit if DXM manages to take out its 200-day moving average at $11.61 with high volume.

    Traders should now look for long-biased trades in DXM as long as it’s trending above some key near-term support levels at $9 or $8.85 and then once it sustains a move or close above Thursday’s high at $10.51 and its 200-day at $11.61 with volume that’s near or above 280,277 shares. If that breakout hits soon, then DXM will set up to re-test or possibly take out its 50-day moving average of $13.72.

Best Income Stocks To Own Right Now: Post Properties Inc. (PPS)

Post Properties, Inc., a real estate investments trust (REIT), together with its subsidiaries, engages in the development, ownership, and management of multifamily apartment communities in the United States. As of December 31, 2007, the company owned 22,578 apartment units in 63 apartment communities, including 1,747 apartment units in 2 communities held in unconsolidated entities and 2,266 apartment units in 7 communities. It is also developing and selling 535 for-sale condominium homes in 4 communities and converting 349 apartment homes into for-sale condominium homes in 2 communities. The company primarily operates in Atlanta, Georgia; Dallas, Texas; Washington, D.C.; and Tampa, Florida metropolitan areas. Post Properties has elected to be taxed as REIT under the Internal Revenue Code and would not be subject to federal income taxes, if it distributes approximately 90% of its taxable income to its shareholders. The company was founded in 1971 and is based in Atlanta, Ge orgia.

Advisors’ Opinion:

  • [By Philip Springer]

    Post Properties Inc. (NYSE: PPS): 14.7%

    Here are the largest homebuilders and their shares’ performance so far this year:

    Lennar Corp. (NYSE: LEN): -2.3%

  • [By Sally Jones] ng>Rate of Return: 30.76%

    Down 6% over 12 months, Post Properties Inc., a residential REIT, has a market cap of $2.46 billion; its shares were traded at around $45.02. The tangible book value is 20.98. PPS trades with a P/E ratio of 29.00 and a P/B of 2.10. The earnings yield is 2.80%.

    Guru Action: As of Sept. 30, 2013, Third Avenue Management holds 422,734 shares values at around $20.9 million.

    PPS is a relatively new holding for the firm, first bought in the second quarter of 2013. The firm bought 422,734 shares at an average price of $49.04, for a loss of 8.2%.

    Track historical pricing, revenue and net income since 1993:

    [ Enlarge Image ]

    Valley National Bancorp (VLY)

    Rate of Return: 26.4%

    Up 5% over 12 months, Valley National Bancorp has a market cap of $2.07 billion; its shares were traded at around $10.40. The tangible book value is 5.28. VLY trades with a P/E ratio of 14.60 and a P/B of 1.30. The earnings yield is 3.80 %.

    Guru Action: As of Sept. 30, 2013, Third Avenue Management holds 1,462,501 shares values at around $13.8 million.

    VLY is another new holding for Third Avenue, first buying 1,462,501 shares in the second quarter of 2013, at an average price of $9.34, for a gain of 11.3%.

    Track historical pricing, revenue and net income since 1990:

    [ Enlarge Image ]

    Brookdale Senior Living Inc. (BKD)

    Rate of Return: 23.14%

    Up 11% over 12 months, Brookdale Senior Living Inc. has a market cap of $3.35 billion; its shares were traded at around $26.94. The tangible book value is 5.97. BKD trades with a P/B of 3.30. The earnings yield is 1.80%.

    Guru Action: As of Sept. 30, 2013, Third Avenue Management holds 658,866 shares values at around $17.429 million.

    Bought in the second quarter of 2013, BKD is another new holding for Third Avenue. The firm made a new buy of 658,866 shares at an average price of $27.55, for a 2.2% loss.

    Trac k historical pricing,

Best Income Stocks To Own Right Now: Herman Miller Inc.(MLHR)

Herman Miller, Inc. engages in the research, design, manufacture, and distribution of interior furniture systems, products, and related services worldwide. It also provides modular systems under the Action Office, Canvas Office Landscape, Ethospace, Resolve, My Studio Environments, and Vivo Interiors brand names; seating products under the Embody, Aeron, Mirra, Setu, Celle, Equa, and Ergon brand names; and storage products under the Meridian and Tu brand names. In addition, the company offers wooden casegoods under the Geiger brand name; freestanding furniture products under the Abak, Intent, Sense, and Envelop brand name; and ergonomic solutions. It markets its products for office, healthcare, industrial, educational, and residential settings through its sales staff, own dealer network, independent dealers and retailers, and independent contract office furniture dealers, as well as through Internet. The company was founded in 1905 and is based in Zeeland, Michigan.

Advisors’ Opinion:

  • [By Ben Levisohn]

    Shares of HNI Corp. have gained 4.9% to $35.17 at 1:45 p.m., while Steelcase (SCS) has risen 0.8% to $16.93, Knoll (KNL) has advanced 2.5% to $18.74 and Herman Miller (MLHR) has ticked up 0.3% to $30.57.

  • [By John Kell and Tess Stynes var popups = dojo.query(“.socialByline .popC”); p]

    Herman Miller Inc.(MLHR) said its fiscal third-quarter earnings rose 18% on broad sales growth and stronger margins. The office-furniture company projected fiscal-fourth-quarter results that were mostly higher than expectations. Shares rose 6.2% to $30.50 premarket.

  • [By Jake L’Ecuyer]

    Shares of Herman Miller (NASDAQ: MLHR) got a boost, shooting up 11.96 percent to $32.14 after the company reported in-line FQ3 adjusted earnings. The company expected Q4 earnings of $0.43 to $0.47 per share on revenue of $485 million to $505 million. However, analysts were projecting earnings of $0.43 per share on revenue of $487.5 million.

Best Income Stocks To Own Right Now: BG Group PLC (BRGXF.PK)

BG Group plc (BG Group) is a natural gas company. The Company is engaged in the exploration, development and production of natural gas and oil. It operates in three business segments: Exploration and Production (E&P), Liquefied Natural Gas (LNG) and Transmission and Distribution (T&D). Effective January 1, 2012, the Company was managed across three regions: Americas and Europe; Africa, Central and South Asia, and Australia and East Asia, supported by Global Energy Marketing and Shipping (GEMS) and BG Advance. The Company has interests in 25 countries on five continents. During the year ended December 31, 2011, the Company acquired an interest in, and operatorship of, offshore blocks L10A (BG Group 40%) and L10B (BG Group 45%) in Kenya. During 2011, the Company acquired additional Marcellus shale properties in partnership with EXCO Resources, Inc. (EXCO). In June 2013, BG Group PLC announced that it has completed the sale of its 65.12% holding in Gujarat Gas Company Limited (G GCL). Advisors’ Opinion:

  • [By Heather Ingrassia]

    On Thursday, August 15, GasLog (GLOG) announced that it had ordered two new 174K cbm Tri-Fuel Diesel Electric LNG carriers from Samsung Heavy Industries. These carriers are expected to be delivered in 2016 which is the same year the company will begin seven-year charters with BG Group (BRGYY.PK) (BRGXF.PK).